DNA Link Named Roche NimbleGen Provider in Korea | GenomeWeb

NEW YORK (GenomeWeb News) – Seoul-based DNA Link will provide Roche NimbleGen's sequence capture technology as a service in Korea through a coupled offering that includes 454 Life Sciences' sequencing technology, Roche said today.

The Certified Service Provider status enables DNA Link to provide NimbleGen's Titanium Optimized Sequence Capture along with the 454 sequencing, the company said. The sequence capture method is used for genomic enrichment and uses NimbleGen's 385K Arrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.